Japan’s Eisai
aims to roll out its groundbreaking Alzheimer’s drug
Leqembi to 1,500 people in China later this year, but expects
growth to accelerate significantly in 2025 as diagnosis.
SHANGHAI, China, Feb. 01, 2024 Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of.
Junshi Biosciences Announces Toripalimab's NDA Accepted by the Singapore Health Sciences Authority streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Junshi Biosciences Announces Toripalimab's NDA Accepted by the Singapore Health Sciences Authority | 02.02.24 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.